American Vanguard (NYSE:AVD) Releases Quarterly Earnings Results, Misses Expectations By $0.22 EPS

American Vanguard (NYSE:AVD) announced its quarterly earnings results on Monday. The basic materials company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.22), Zacks reports. American Vanguard had a negative net margin of 9.68% and a negative return on equity of 4.94%. The firm had revenue of $150.69 million during the quarter, compared to analysts’ expectations of $163.00 million.

Here are the key takeaways from American Vanguard’s conference call:

• Completed a debt refinancing with two term loans (Centerbridge and a BMO-led syndicate) with no equity dilution, which management says secures runway and financial stability despite higher interest costs.
• Announced rationalization of the Los Angeles manufacturing facility and a move of global HQ to Irvine, expected to save about $4.0M and $0.5M annually respectively and improve utilization at the Axis, Alabama site.
• 2025 sales fell to $515M (down 6%), adjusted EBITDA was $39.2M (slightly below target), and a roughly $50M drop in customer prepayments increased year‑end nominal debt levels.
• Company forecasts a meaningful product-driven growth runway—five North American launches in 2026, a goal of 25 NA registrations by 2031, and an estimated $100M of incremental annual revenue from in‑development products by 2030–31.
• Management expects operational improvement from supply‑chain hires, cost containment and a software rollout (targeting inventory turns of 2.25), and guided 2026 adjusted EBITDA of $44M–$48M on $530M–$550M of sales; the company also remediated audit material weaknesses and filed its Form 10‑K.

American Vanguard Price Performance

NYSE AVD opened at $3.47 on Wednesday. The company has a market cap of $98.79 million, a PE ratio of -1.98 and a beta of 1.23. The firm’s 50 day moving average price is $4.67 and its 200-day moving average price is $4.78. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.90 and a current ratio of 1.77. American Vanguard has a 52-week low of $3.28 and a 52-week high of $5.92.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of American Vanguard in a research report on Wednesday, January 21st. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $12.00.

Institutional Trading of American Vanguard

A number of hedge funds have recently bought and sold shares of AVD. Strs Ohio acquired a new stake in shares of American Vanguard in the 1st quarter worth $28,000. nVerses Capital LLC acquired a new position in American Vanguard during the 4th quarter valued at about $42,000. Virtu Financial LLC purchased a new stake in American Vanguard in the fourth quarter valued at about $52,000. Jain Global LLC purchased a new stake in American Vanguard in the fourth quarter valued at about $53,000. Finally, XTX Topco Ltd acquired a new stake in American Vanguard in the second quarter worth about $57,000. Hedge funds and other institutional investors own 79.00% of the company’s stock.

About American Vanguard

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.